Fortress Biotech Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Fortress Biotech stock has a consensus rating of "Strong Buy" and an average price target of $11. The average 1-year stock price forecast is 257.14% higher than the current stock price, while the lowest is $5.00 (+62.34%) and the highest is $17 (+451.95%).

Price Target: $11 (+257.14%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$11	$11	$17
Change	+62.34%	+257.14%	+257.14%	+451.95%

* Price targets were last updated on May 18, 2026.

Analyst Ratings

The average analyst rating for Fortress Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Maintains $4.5 → $5	Buy	Maintains	$4.5 → $5	+62.34%	May 18, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Reiterates $17	Buy	Reiterates	$17	+451.95%	Feb 23, 2026

Financial Forecast

Revenue This Year

79.88M

from 63.26M

26.26%

from 63.26M

Revenue Next Year

134.15M

from 79.88M

67.95%

from 79.88M

EPS This Year

-0.40

from -

EPS Next Year

18.60

from -0.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	68.79M	75.74M	84.51M	57.68M	63.26M	79.88M
Revenue Growth	50.86%	10.11%	11.58%	-31.76%	9.69%	26.26%
Gross Profit	-92.16M	-89.91M	-44.45M	-20.09M	30.44M	60.71M
Gross Margin	-133.97%	-118.70%	-52.60%	-34.82%	48.11%	76.00%
Operating Income	-179.00M	-203.56M	-136.06M	-106.69M	-70.22M	-17.98M
Net Income	-64.70M	-86.58M	-60.64M	-46.00M	6.82M	90.51M
EPS	-	-	-	-	-	-0.40
Free Cash Flow	-67.29M	-118.40M	-98.15M	-53.06M	-47.29M	-33.50M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	79.9M
Avg	79.9M
Low	79.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	26.3%
Avg	26.3%
Low	26.3%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.40
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-